Halozyme Therapeutics, Inc. Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 AGIO
|
Agios Pharmaceuticals, Inc. | $45.21 | $2.70 B | -7.55 | 383 | $26.82 M |
 ALEC
|
Alector, Inc. | $4.98 | $420.24 M | -3.14 | 245 | $97.06 M |
 ALNY
|
Alnylam Pharmaceuticals, Inc. | $266.05 | $19.33 B | -57.65 | 2100 | $1.83 B |
 APLS
|
Apellis Pharmaceuticals, Inc. | $26.82 | $4.90 B | -11.77 | 702 | $396.59 M |
 ASND
|
Ascendis Pharma A/S | $127.76 | $7.77 B | -14.19 | 879 | $266.72 M |
 BGNE
|
BeiGene, Ltd. | $208.40 | $17.07 B | -20.76 | 10000 | $2.46 B |
 BMRN
|
BioMarin Pharmaceutical Inc. | $65.83 | $15.32 B | 76.12 | 3401 | $2.42 B |
 BPMC
|
Blueprint Medicines Corporation | $97.03 | $6.47 B | -21.48 | 638 | $249.38 M |
 CERE
|
Cerevel Therapeutics Holdings, Inc. | $44.96 | $7.29 B | -14.66 | 355 | $0 |
 CYTK
|
Cytokinetics, Incorporated | $51.97 | $6.05 B | -9.78 | 423 | $7.53 M |
 DICE
|
DICE Therapeutics, Inc. | $47.55 | $2.27 B | -21.91 | 71 | $0 |
 EWTX
|
Edgewise Therapeutics, Inc. | $35.75 | $1.65 B | -11.47 | 97 | $0 |
 EXEL
|
Exelixis, Inc. | $34.91 | $6.37 B | 33.66 | 1310 | $1.83 B |
|
INBX
|
Inhibrx Biosciences, Inc. | $15.63 | $241.02 M | -1.44 | 166 | $1.80 M |
|
INSM
|
Insmed Incorporated | $68.46 | $9.17 B | -10.87 | 912 | $305.21 M |
 LEGN
|
Legend Biotech Corporation | $44.85 | $8.31 B | -17.66 | 2200 | $285.14 M |
 LRMR
|
Larimar Therapeutics, Inc. | $7.34 | $611.84 M | -9.99 | 42 | $0 |
|
PTGX
|
Protagonist Therapeutics, Inc. | $44.25 | $2.04 B | 13.7 | 125 | $60.00 M |
 RARE
|
Ultragenyx Pharmaceutical Inc. | $51.37 | $3.44 B | -5.21 | 1276 | $434.25 M |
 SGEN
|
Seagen Inc. | $228.74 | $43.15 B | -57.19 | 3256 | $1.96 B |
 VRDN
|
Viridian Therapeutics, Inc. | $22.98 | $776.72 M | -2.71 | 94 | $314,000 |